Haemonetics published a randomized clinical trial in JAMA evaluating cold-stored platelets stored for up to 21 days compared with standard room-temperature platelets stored for 5–7 days in patients with active bleeding following cardiac surgery.
Published
Signal category
Research & Knowledge
Quote
“Recently published in JAMA, the CHIPS randomized clinical trial evaluated cold-stored platelets stored for up to 21 days compared with standard room-temperature platelets stored for 5–7 days in patients with active bleeding following cardiac surgery.”
— Haemonetics team
Company
Haemonetics
We make it possible. You make it matter.
- Industry
- Medical Equipment Manufacturing
- Location
- Boston, US
- Company size
- 2,540 employees
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience. To learn more about Haemonetics, visit www.haemonetics.com.
Founded 1971